PAH Clinical Trials: Why Diversity and Inclusion Matter
I’m Aware That I’m Rare: the phaware® podcast
Episode 529 - Tijana Milinic, MD & Lia Barros, DPN
Dr. Tijana Milinic and Lia Barros, DNP, from the University of Washington take a deep dive into the world of pulmonary arterial hypertension (PAH) clinical trials and discuss why diversity and inclusion matter. They explore the hidden biases in medical research and the real-world consequences of exclusion.
Racial and Ethnic Disparities in PAH Treatment
I’m Aware That I’m Rare: the phaware® podcast
Episode 528 - Lana Melendres-Groves, MD
Dr. Lana Melendres-Groves dives into her research on racial and ethnic disparities in PAH treatment. From differences in medication access to the role of social determinants of health, she explores how systemic barriers impact care and what steps can be taken to ensure equity and inclusivity in PAH management.